Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Fatima Aerts‐Kaya"'
Autor:
Burcu Pervin, Merve Gizer, Mehmet Emin Şeker, Özgür Doğuş Erol, Sema Nur Gür, Ece Gizem Polat, Bahar Değirmenci, Petek Korkusuz, Fatima Aerts‐Kaya
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 5, Pp n/a-n/a (2024)
Abstract Inflammatory bowel disease (IBD) is characterized by a chronically dysregulated immune response in the gastrointestinal tract. Bone marrow multipotent mesenchymal stromal cells have an important immunomodulatory function and support regenera
Externí odkaz:
https://doaj.org/article/328362d20c6e459aa96a1636f9f7dde9
Autor:
Mehmet Emİn Şeker, Özgür Doğuş Erol, Burcu Pervİn, Gerard Wagemaker, Nico Peter VAN Til, Fatima Aerts-Kaya
Publikováno v:
HemaSphere, Vol 7, p e6316019 (2023)
Externí odkaz:
https://doaj.org/article/d90911c59fc34f36a9d789872ffe8480
Autor:
Fatima Aerts-Kaya, Niek P. van Til
Publikováno v:
Pharmaceutics, Vol 15, Iss 11, p 2522 (2023)
Leukodystrophies are a heterogenous group of inherited, degenerative encephalopathies, that if left untreated, are often lethal at an early age. Although some of the leukodystrophies can be treated with allogeneic hematopoietic stem cell transplantat
Externí odkaz:
https://doaj.org/article/ca0f9b3814034bc8a610a1e73c752ec3
Autor:
Gülen Güney-Esken, Özgür Doğuş Erol, Burcu Pervin, Gülben Gürhan Sevinç, Tamer Önder, Elif Bilgiç, Petek Korkusuz, Ayşen Günel-Özcan, Duygu Uçkan-Çetinkaya, Fatima Aerts-Kaya
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Abstract Background Griscelli syndrome type 2 (GS-2) is a rare, autosomal recessive immune deficiency syndrome caused by a mutation in the RAB27A gene, which results in the absence of a protein involved in vesicle trafficking and consequent loss of f
Externí odkaz:
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
Publikováno v:
Trakya University Journal of Natural Sciences, Vol 20, Pp 17-32 (2019)
Stem cell therapy offers a great advantage for the development of new treatments in the field of regenerative and restorative medicine. However, the use of stem cell therapies and their clinical indications can even be further improved using genetic
Externí odkaz:
https://doaj.org/article/0ec320dc592d48feb65de1b7cd4b03fb
Publikováno v:
World Journal of Stem Cells
Despite a vast amount of different methods, protocols and cryoprotective agents (CPA), stem cells are often frozen using standard protocols that have been optimized for use with cell lines, rather than with stem cells. Relatively few comparative stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8817137fcdab29e57b7af38326a1525
http://europepmc.org/articles/PMC8474714
http://europepmc.org/articles/PMC8474714
Autor:
Gülben Gürhan Sevinç, Elif Bilgiç, Özgür Doğuş Erol, Fatima Aerts-Kaya, Aysen Gunel-Ozcan, Tamer T. Onder, Duygu Uckan-Cetinkaya, Burcu Pervin, Petek Korkusuz, Gülen Güney-Esken
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background: Griscelli syndrome type 2 (GS-2) is a rare, autosomal recessive immune deficiency syndrome caused by a mutation in the RAB27A gene, which results in the absence of a protein involved in vesicle trafficking and consequent loss of function
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99b4da836eb8f9bd97526e935d04be45
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
https://doaj.org/article/39c37f9ef6a3443daf600d3a7a06c2f6
Publikováno v:
Biotechnic & Histochemistry. 97:79-89
Multipotent mesenchymal stromal cells (MSC) can be isolated from many tissues, including bone marrow (BM) and placenta (PL). Human placenta can be obtained readily without invasive procedures. There may be differences, however, in differentiation cap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7487cfa5a534dff42bef2a2c2393523
https://doi.org/10.1080/10520295.2021.1885739
https://doi.org/10.1080/10520295.2021.1885739
Publikováno v:
International Journal of Hematology. 113:5-9
In recent years, multipotent mesenchymal stromal cells (MSCs) have demonstrated tremendous potential for use in regenerative medicine. CXCR4, the receptor for CXCL12, is highly expressed by bone marrow (BM) MSCs and the CXCR4/CXCL12 axis has been sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af9d3be098565296204082c08633d228
https://doi.org/10.1007/s12185-020-03043-0
https://doi.org/10.1007/s12185-020-03043-0
Autor:
Özgür Özyüncü, F. Duygu Uçkan-Çetinkaya, Aynura Mammadova, Fatima Aerts-Kaya, Gerard Wagemaker, Trudi P. Visser, Burcu Pervin
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:634-642
The newly developed 6-hydroxychromanol derivate SUL-109 was shown to provide protection during hypothermic storage of several cell lines, but has not been evaluated in hematopoietic stem cells (HSCs). Hypothermic preservation of HSCs would be preferr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::635be5b890ea6f067a0c8f5e94728169
https://doi.org/10.1016/j.bbmt.2019.12.770
https://doi.org/10.1016/j.bbmt.2019.12.770